Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor. [electronic resource]
Producer: 20050620Description: 1899-909 p. digitalISSN:- 1078-0432
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Aged
- CD4-Positive T-Lymphocytes -- immunology
- CD56 Antigen -- analysis
- CD8-Positive T-Lymphocytes -- immunology
- Carcinoma, Squamous Cell -- drug therapy
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Interferon-gamma -- biosynthesis
- Interleukin-12 -- administration & dosage
- Killer Cells, Natural -- immunology
- Lymph Nodes -- anatomy & histology
- Male
- Middle Aged
- RNA, Messenger -- biosynthesis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.